ABSTRACT
Central nervous system diseases are a prevailing cause of morbidity and mortality worldwide, and are influenced by environmental and biological factors including genetic risk. Here we generated genome-wide genetic data on a large cohort of brain tissue donors with in-depth clinical and neuropathological phenotyping, allowing for broad investigations into the risk and mechanisms of these neurological, neurodevelopmental, and psychiatric conditions. This resource consists of 9,663 donors with array-based genotyping and 9,543 donors with whole-genome sequencing completed. The clinical diagnoses of these donors include 148 central nervous system diseases clustered in 15 broad categories by ICD-10 coding. These donors were collected by six repositories comprising the NIH NeuroBioBank, with an average participant age of 60 years. While primarily older individuals of European descent, the cohort also contains younger donors and individuals from non-European backgrounds. Variants detected by Whole-Genome Sequencing (WGS) were called genome-wide and annotated to describe their functional impact, resulting in 171,121,209 unique mutations and 1,078,774 non-silent mutations. This whole-genome resource has been made available in the NIMH Data Archive (nda.nih.gov) and accompanying deep demographic and phenotypic descriptions are available at the NeuroBioBank Portal (neurobiobank.nih.gov). To illustrate an application of this resource, we replicated the strong association observed in previous studies between pathogenic CAG repeat expansions in the HTT gene with the clinical diagnosis of Huntington’s disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Processing of tissue specimens at the University of Miami for genotyping and WGS was supported by HHS contract 75N95019C00050. Tissue biobanking at University of Miami was supported by 75N95019C00050 and HHSN271201300028. Tissue biobanking at the University of Maryland was supported by contract numbers HHSN27520090011C, HHSN271201400045C, and 75N95019C00048. Tissue biobanking at the University of Pittsburgh was supported by contract number 75N95019C00047. Tissue biobanking at the University of California, Los Angeles was supported by contract number 75N95019C00045. Tissue biobanking at the Icahn School of Medicine at Mount Sinai was supported by contract number 75N95019C00049. Work at the Harvard Tissue Resource Center (HBTRC) was supported by contract number 75N95019C00046. Sequencing and analysis at The American Genome Center, and the Center for Military Precision Health at Uniformed Services University was supported by contract numbers HU00012220044.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of University of Miami gave ethical approval for this work. Ethics committee/IRB of University of Maryland gave ethical approval for this work Ethics committee/IRB of University of Pittsburgh gave ethical approval for this work Ethics committee/IRB of University of California, Los Angeles gave ethical approval for this work Ethics committee/IRB of Icahn School of Medicine at Mount Sinai gave ethical approval for this work Ethics committee/IRB of Harvard University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵16 Co-first author
Data Availability
Data from this study is available in the NIMH Data Archive, accessible at the following URL (https://nda.nih.gov/edit_collection.html?id=3917). To access, search and analyze this dataset, apply for access using the following URL (https://nda.nih.gov/nda/access-data-info). Tutorials further describing data access are available at the following URL (https://nda.nih.gov/nda/webinars-and-tutorials#tutorials). For further questions about data access, contact NDAHelp{at}mail.nih.gov.
